Clinical Trial: Safety and PK Multi-dose Study of TAF/EVG Vaginal Insert
Study Status: Completed
Recruit Status: RECRUITING
Condition: Safety Issues
Study Type: INTERVENTIONAL
Official Title: A Phase I Randomized, Placebo-controlled, Double-blind Study to Assess Safety, Pharmacokinetics, and Modeled Pharmacodynamics of a Vaginal Insert Containing Tenofovir Alafenamide and Elvitegravir
Brief Summary:
MATRIX-001 will examine the safety, PK, modeled PD, and acceptability of inserts containing the combination of TAF and EVG applied vaginally, daily for 3 days, then every other day for 14 days.The inserts are ultimately intended to be the basis of an event-driven, on-demand method for prevention of HIV and HSV sexual infection.
Read more